Craniofacial Abnormalities: Clinical Trials

12 trials for Craniofacial Abnormalities, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 recruiting, 2 terminated, 2 withdrawn. 12 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 412Completed 4, Recruiting 3, Terminated 2, Withdrawn 2, Active not recruiting 1

Follow Craniofacial Abnormalities: new trials by email Literature Review of Craniofacial Abnormalities trials Research Report on Craniofacial Abnormalities

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery
Methadone hydrochloride, Fentanyl/Hydromorphone - Cleft Palate, Pain
Phase 4RecruitingDuke University602025-06-042026-04-14
Nebulized Dexmedetomidine Combined With Ketamine Versus Nebulized Dexmedetomidine for Cleft Palate
Nebulization of dexmedetomidine and ketamine, Nebulization of dexmedetomidine - Sedation, Emergence Delirium
Phase 4RecruitingAssiut University602024-04-102025-10-03
Effects of Antiemetic Agents in Orthognathic Surgery Patients
Intravenous drug - Emesis, Postoperative, Maxillofacial Abnormalities
Phase 4CompletedBezmialem Vakif University662020-04-142024-06-12
The Use of Fibrin Sealant to Reduce Post Operative Pain in Cleft Palate Surgery
Tisseel - Cleft Palate
Phase 4WithdrawnUniversity of Alberta2019-09-012022-05-20
Evaluation of Trigeminal Nerve Blockade
Ropivacaine, Sham Comparator - Mouth Abnormalities, Cleft Palate
Phase 4Active not recruitingUniversity of Florida402018-11-202026-07-21
A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD
Crisaborole ointment, 2%, Hydrocortisone butyrate cream, 0.1%, Pimecrolimus cream, 1% - Atopic Dermatitis
Phase 4TerminatedPfizer2372018-04-272022-01-10
Dexmedetomidine vs Placebo for Pediatric Cleft Palate Repair
Dexmedetomidine, Placebo - Cleft Palate
Phase 4WithdrawnBaylor College of Medicine2017-12-312019-02-05
Human Fibrinogen Concentrate in Pediatric Cardiac Surgery
RiaStAP, Saline - Hypofibrinogenemia, Afibrinogenemia
Phase 4CompletedNicklaus Children's Hospital f/k/a Miami Children's Hospital302017-06-012021-09-16
The Efficacy and Population Pharmacokinetics of Tranexamic Acid for Craniosynostosis Surgery
high dose TXA, Low dose TXA - Craniosynostosis
Phase 4CompletedBoston Children's Hospital662014-08-012020-01-31
Acid Tranexamic Effectiveness in Reducing the Intraoperative Bleeding in Palatoplasty
Tranexamic Acid, Saline - Cleft Palate, Hemorrhage
Phase 4CompletedProfessor Fernando Figueira Integral Medicine Institute662013-12-012015-04-21
Tranexamic Acid for Craniofacial Surgery
Tranexamic acid, saline - Craniosynostosis, Bleeding
Phase 4TerminatedUniversity of Pittsburgh202008-07-012017-02-15
The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome
methylphenidate, fluoxetin, risperidone - Velocardiofacial Syndrome, Williams Syndrome
Phase 4RecruitingThe Chaim Sheba Medical Center4002001-05-012026-03-18

Narrower conditions

Cleft Palate (6)  ·  Craniosynostoses (2)  ·  Hemorrhage (2)  ·  Pain (2)  ·  Afibrinogenemia (1)  ·  Agnosia (1)  ·  Congenital Abnormalities (1)  ·  Dermatitis, Atopic (1)  ·  DiGeorge Syndrome (1)  ·  Emergence Delirium (1)  ·  Fragile X Syndrome (1)  ·  Heart Defects, Congenital (1)  ·  Hemostatic Disorders (1)  ·  Mandibulofacial Dysostosis (1)  ·  Maxillofacial Abnormalities (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (12)  ·  Musculoskeletal Abnormalities (12)  ·  Musculoskeletal Diseases (12)  ·  Congenital Abnormalities (11)  ·  Stomatognathic Diseases (7)  ·  Stomatognathic System Abnormalities (7)  ·  Jaw Abnormalities (6)  ·  Jaw Diseases (6)  ·  Maxillofacial Abnormalities (6)  ·  Mouth Diseases (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Mouth Abnormalities (5)  ·  Neurologic Manifestations (5)  ·  Bone Diseases (4)

Interventions

Sodium Chloride (4)  ·  Tranexamic Acid (3)  ·  Dexmedetomidine (1)  ·  Fentanyl (1)  ·  Fibrin Tissue Adhesive (1)  ·  Fibrinogen (1)  ·  Fluoxetine (1)  ·  Hydromorphone (1)  ·  Infusion Pumps (1)  ·  Ketamine (1)  ·  Methadone (1)  ·  Methylphenidate (1)  ·  Risperidone (1)  ·  Ropivacaine (1)  ·  Saline Solution (1)

Sponsors

Assiut University (1)  ·  Baylor College of Medicine (1)  ·  Bezmialem Vakif University (1)  ·  Boston Children's Hospital (1)  ·  Duke University (1)  ·  Nicklaus Children's Hospital f/k/a Miami Children's Hospital (1)  ·  Pfizer (1)  ·  Professor Fernando Figueira Integral Medicine Institute (1)  ·  The Chaim Sheba Medical Center (1)  ·  University of Alberta (1)  ·  University of Florida (1)  ·  University of Pittsburgh (1)

Countries

United States (6)  ·  Canada (1)  ·  Egypt (1)  ·  Germany (1)  ·  Israel (1)  ·  Italy (1)  ·  Poland (1)  ·  Sweden (1)  ·  Switzerland (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Cameron R Smith, MD, PhD (1)  ·  Chris D. Glover, MD (1)  ·  Christopher Tirotta, MD (1)  ·  Guilherme C Arantes (1)  ·  Jaret L Olson, MD FRCSC (1)  ·  Lisa M. Einhorn, M.D. (1)  ·  Nicola Disma, MD (1)  ·  Susan Goobie, MD (1)

Results publications

PMID 32620262, PMID 35305111, PMID 39824505

NIH funding

2018 (1)